G266-1410 Screening compound: 3-[1,3-dimethyl-2-oxo-6-(pyrrolidin-1-yl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-1-[(3-fluorophenyl)methyl]urea

G266-1410 Screening compound: 3-[1,3-dimethyl-2-oxo-6-(pyrrolidin-1-yl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-1-[(3-fluorophenyl)methyl]urea
G266-1410 Screening compound: 3-[1,3-dimethyl-2-oxo-6-(pyrrolidin-1-yl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-1-[(3-fluorophenyl)methyl]urea alternative view

Chemical Structure Depiction of ChemDiv screening compound G266-1410
3-[1,3-dimethyl-2-oxo-6-(pyrrolidin-1-yl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-1-[(3-fluorophenyl)methyl]urea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G266-1410

Molecular Formula

C21H24FN5O2 (C21 H24 FN5 O2)

Compound Name

3-[1,3-dimethyl-2-oxo-6-(pyrrolidin-1-yl)-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-1-[(3-fluorophenyl)methyl]urea

IUPAC name

3-[13-dimethyl-2-oxo-6-(pyrrolidin-1-yl)-23-dihydro-1H-13-benzodiazol-5-yl]-1-[(3-fluorophenyl)methyl]urea

SMILES

CN(c(c(N1C)c2)cc(NC(NCc3cccc(F)c3)=O)c2N2CCCC2)C1=O

InChI

InChI=1S/C21H24FN5O2/c1-25-18-11-16(24-20(28)23-13-14-6-5-7-15(22)10-14)17(27-8-3-4-9-27)12-19(18)26(2)21(25)29/h5-7,10-12H,3-4,8-9,13H2,1-2H3,(H2,23,24,28)

InChI Key

YOQXENJZAVISTA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27212084

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

397.45

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.356

Distribution Coefficient, logD

3.355

Water Solubility, LogSw

-3.65

Polar Surface Area

54.368

Acid Dissociation Constant (pKa)

10.12

Base Dissociation Constant (pKb)

11.62

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

G266-1410 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with G266-1410 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G266-1410?
Check Price and Availability of G266-1410, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G266-1410 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G266-1410
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G266-1410
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G266-1410 available by request